Industry News

BioLegend® and New York Genome Center® Enter into Exclusive Global License and Research Agreement for CITE-seq™, a Novel Technique for Multidimensional Single Cell Analysis

BioLegend, Inc. (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq™ technology for use in the research field. CITE-seq™, Cellular Indexing of Transcriptomes and ...

Read More »

Researchers Uncover Advanced Cancer Resistance Pathway

The study highlights the ability of cells to resist drug treatment through a non-genetic cell state transition by changing their gene expression patterns and signaling pathways. A study in collaboration with the California Institute of Technology showed on December 12, ...

Read More »

Scipio Bioscience Nabs €1.2M in Seed Funding

NEW YORK (GenomeWeb) – Scipio Bioscience said today that it has completed a seed financing round of €1.2 million ($1.4 million) to fund development and commercialization of its first prototype kit for single-cell transcriptomics. Paris-based Seventure Partners’ Quadrivium I seed ...

Read More »